Over the past decades, medicine has undergone a radical transformation from traditional treatment approaches based on trial and error toward a more precise and personalized approach known as Personalized Medicine. This modern field focuses on analyzing the patient’s genetic makeup, in addition to environmental factors and lifestyle, in order to design preventive and therapeutic strategies tailored to each individual. First: What Is Personalized Medicine? In traditional medicine, most patients suffering from the same disease, such as lung cancer or arthritis, receive the same Standard of Care treatment protocol. However, physicians observe significant differences in patients’ responses to treatment; some respond well, while others experience little or no improvement or suffer from severe side effects. This variation is largely attributed to subtle differences in DNA. Personalized medicine aims to understand these differences and apply the principles of Pharmacogenomics to determine the most appropriate medication and optimal dosage for each patient. Second: Modern Medical Applications : Malignant tumors are among the most prominent areas of application of personalized medicine. It is now possible to perform genomic sequencing of tumors rather than determining treatment solely based on the affected organ, as is commonly the case with breast or colorectal cancer. This approach involves analyzing genetic mutations within the cancer cells themselves. Targeted therapies, such as Trastuzumab, are also used to treat patients with HER2-positive breast cancer, contributing to increased treatment effectiveness while reducing its effects on healthy cells. In the field of rare genetic diseases, Next-Generation Sequencing (NGS) technologies enable the diagnosis of diseases that previously required years of inconclusive investigations. The causes of some metabolic disorders and muscular dystrophies can now be identified within a matter of weeks, allowing treatment to be initiated using gene therapies or targeted medications. In cardiovascular diseases, genetic analysis helps determine patients’ responses to certain medications. For example, the metabolism of Warfarin and Clopidogrel is affected by liver enzymes produced by specific genes, such as CYP2C9 and CYP2C19, which helps physicians select the most appropriate dosage and therapeutic strategy and reduce the risks of bleeding or thrombosis. Third: Future Challenges and Obstacles : Despite the promising prospects of personalized medicine, it faces several major challenges, most notably the high cost of advanced genetic testing and targeted biological therapies compared with conventional treatments. The management of Big Data also represents an important challenge, as analyzing billions of nucleotide bases in DNA requires advanced computational capabilities, in addition to the use of artificial intelligence and complex algorithms to interpret genetic data. Ethical and privacy concerns are also significant, as protecting patients’ genetic data requires strict legal frameworks to prevent its misuse, unauthorized access, or disclosure. Personalized medicine represents a new era in healthcare, shifting medical practice from merely responding to disease toward prevention and carefully targeted treatment based on individual patient characteristics. With the development of artificial intelligence technologies and the decreasing costs of genomic analysis, this approach is expected to become one of the fundamental standards of medical practice in the near future. Zahraa Jawad. Al Mustaqbal University The First University in Iraq